Olivia Jew

Olivia Jew

Third Year Resident

Start Year


What are your career interests?

Healthcare system innovation, teledermatology, healthcare disparities, quality improvement.

Why did you choose Duke for residency training?

First, I was drawn to Duke Dermatology’s balance of excellent clinical training, diverse patient population, and sense of community among residents and faculty. Second, the strength of the broader Duke health system offers many synergistic learning opportunities in fields related to Dermatology. Finally, the quality of life in Durham is fantastic!

Education & Training

Undergraduate:  Stanford University, BA with Honors, Human Biology, 2014

Medical School: Perelman School of Medicine at the University of Pennsylvania, MD, 2020

Internship: Internal Medicine, Duke University, 2020 - 2021

Residency: Dermatology, Duke University, 2021 - 2024

Additional degree: The Wharton School at the University of Pennsylvania, MBA with Honors, 2020

Awards & Honors

  • Phi Beta Kappa
  • T32 NIH Training Grant recipient
  • University of Pennsylvania Class of 1962 and 1958 scholarships recipient
  • Joseph Wharton Fellowship recipient
  • Edward B. Shils/Leonard L. Zeidman Fellowship in Entrepreneurship recipient

Publications & Presentations

  • Jew O.S., Okawa J., Barbieri J.S., McCaffrey J., Hayward E., & Werth V.P. Evaluating the effect of prior authorizations in patients with complex dermatologic conditions. Journal of the American Academy of Dermatology. 2020, Dec; 83(6):1674-1680. Cited in PubMed; PMID: 32622138.
  • Jew O.S., Murthy A.S., Danley K., & McMahon P.J. Implementation of a pediatric provider-to-provider store-and-forward teledermatology system: Effectiveness, feasibility, and acceptability in a pilot study. Pediatric Dermatology. 2020, Nov; 37(6): 1106-1112. Cited in PubMed; PMID: 32869352.
  • Jew O.S., Okawa J., Barbieri J.S., McCaffrey J., Hayward E., & Werth V.P. (May, 2019). The impact of prior authorizations for patients with complex dermatological conditions. Poster presented at: Society for Investigative Dermatology; Chicago, IL, USA.
  • Jew O.S., Okawa J., Barbieri J.S., & Werth V.P. (March, 2019). The impact of prior authorizations for patients with complex dermatological conditions Poster presented at: Penn Dermatology Trainee Research Day; Philadelphia, PA, USA.
  • Jew O.S., Provini L.E., & Treat J.R. Severe vemurafenib-induced photosensitivity in a 6-year-old boy. Pediatric Dermatology. 2019, Jan; 36(1): e62-e63. Cited in PubMed; PMID: 30474875.
  • Jew O., & Rosin R. (2019). Rapid Prototyping Strategies: Making the Most of Your Idea. In N.S. Gooneratne (Ed.), Academic Entrepreneurship (pp. 6). Philadelphia: University of Pennsylvania.
  • Etzkorn J.R., Jew O.S., Shin T.M., Sobanko J.F., Neal D.E., & Miller C.J. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation. Journal of the American Academy of Dermatology. 2018, Dec; 79(6): 1109-1116.e1. Cited in PubMed; PMID: 30003986.
  • Jew O., Miller C.J., Shin T.M., Sobanko J.F., & Etzkorn J.R. Diagnostic Change From Atypical Intraepidermal Melanocytic Proliferation to Melanoma is More Likely When Clinically Visible Residual Pigment Remains After Biopsy. Dermatologic Surgery. 2018, Jul; 44(7): 1024-1026. Cited in PubMed; PMID: 29077633.
  • Fiks A.G., Fleisher L., Berrigan L., Sykes E., Mayne S.L., Gruver R., Halkyard K., Jew O.S., FitzGerald P., Winston F., & McMahon P. Usability, Acceptability, and Impact of a Pediatric Teledermatology Mobile Health Application. Telemedicine and e-Health. 2018, Mar; 24(3): 236-245. Cited in PubMed; PMID: 28731848.
  • O'Connor D.M., Jew O.S., Perman M.J., Castelo-Soccio L.A., Winston F.K., & McMahon P.J. Diagnostic Accuracy of Pediatric Teledermatology Using Parent-Submitted Photographs: A Randomized Clinical Trial. JAMA Dermatology. 2017, Dec; 153(12): 1243-1248. Cited in PubMed; PMID: 29141082.
  • Etzkorn, J.R., Jew O., Miller C.J., Shin T.M., & Sobanko J.F. (October, 2017). Photographic residual lesions may predict diagnostic change of atypical intraepidermal melanocytic proliferation (AIMP) treated with Mohs Microsurgery (MMS) Oral Presentation presented at: American Society for Dermatologic Surgery; Chicago, IL, USA.
  • Etzkorn, J.R., Jew, O.S., Miller, C.J., Sobanko, J.F., & Shin, T.M. (October, 2017). Mohs Micrographic Surgery (MMS) for Atypical Intraepidermal Melanocytic Proliferation (AIMP) Poster presented at: American Society for Dermatologic Surgery; Chicago, IL, USA.
  • Jew, O.S., McMahon, P.J., Fiks, A., Berrigan, L., Sykes, E., Gruver, R., Halkyard, K., Winston, F., & Fleisher, L. (July, 2017). Direct- to-patient teledermatology mobile health app aimed at shortening wait times for new patients Poster presented at: World Congress of Pediatric Dermatology; Chicago, IL, USA.
  • Jew O.S., Cornejo C.M., Spaccarelli N., Vittorio C.C., Samimi S., Rook A.H., Haun P.L., & Kim E.J. A case of retiform mycosis fungoides. Global Dermatology. 2016, Sep; 3(5): 385-386.
  • Houschyar K.S., Momeni A., Maan Z.N., Pyles M.N., Jew O.S., Strathe M., & Michalsen A. Medical leech therapy in plastic reconstructive surgery. Wiener Medizinische Wochenschrift. 2015, Oct; 165(19-20): 419-25. Cited in PubMed; PMID: 26297126.
  • Houschyar K.S., Momeni A., Pyles M.N., Cha J.Y., Maan Z.N., Duscher D., Jew O.S., Siemers F., & van Schoonhoven J. The Role of Current Techniques and Concepts in Peripheral Nerve Repair. Plastic Surgery International. 2016, Jan; 2016(4175293): 8. Cited in PubMed; PMID: 26904282.
  • Mouraret S., Houschyar K.S., Hunter D.J., Smith A.A., Jew O.S., Girod S., & Helms J.A. Cell viability after osteotomy and bone harvesting: comparison of piezoelectric surgery and conventional bur. International Journal of Oral & Maxillofacial Surgery. 2014, Aug; 43(8): 966-71. Cited in PubMed; PMID: 24721169.